Covered recipient · General Payments record
HUNG G HOANG
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2023
$1,856.02
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $297.48 | 12 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Gilead Sciences, Inc. | $244.16 | 9 |
| Novo Nordisk AS | $53.32 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | $26.70 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025595271 | CMS |
| Gilead Sciences, Inc. | $7.39 | 02/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026094617 | CMS |
| Gilead Sciences, Inc. | $26.42 | 03/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025598225 | CMS |
| Gilead Sciences, Inc. | $21.80 | 04/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025752491 | CMS |
| Gilead Sciences, Inc. | $8.09 | 05/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026088151 | CMS |
| Gilead Sciences, Inc. | $7.10 | 06/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026098057 | CMS |
| Gilead Sciences, Inc. | $7.91 | 07/19/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1026089921 | CMS |
| Gilead Sciences, Inc. | $120.44 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025514545 | CMS |
| Gilead Sciences, Inc. | $18.31 | 08/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1025881711 | CMS |
| Novo Nordisk Inc | $19.45 | 02/11/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002996741 | CMS |
| Novo Nordisk Inc | $19.30 | 03/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002996729 | CMS |
| Novo Nordisk Inc | $14.57 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002996717 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.